Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
91 hedge funds and large institutions have $257M invested in Syneron Medical Ltd in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 11 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
109% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 11
41% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 22
29% more capital invested
Capital invested by funds: $199M → $257M (+$58.2M)
14% more funds holding
Funds holding: 80 → 91 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGI
Discovery Group I
Chicago,
Illinois
|
+$11.8M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.02M |
| 3 |
Millennium Management
New York
|
+$3.72M |
| 4 |
Two Sigma Investments
New York
|
+$2.02M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$1.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$15.2M |
| 2 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$5.93M |
| 3 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$4.84M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$3.63M |
| 5 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
-$1.36M |
ELOS Hedge Fund Activity: Q1 2017 in Review
91 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2017, worth a combined $257M — up 29% from $199M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ELOS positions and 11 closed out — a net gain of 12 holders — while 31 added to existing stakes and 22 trimmed.
The largest buyer was Discovery Group I, opening a new position worth an estimated $11.8M. The largest seller was Senvest Management, cutting an estimated $15.2M.
- 91 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2017, up from 80 in Q4 2016.
- Funds reported $257M of Syneron Medical Ltd stock for Q1 2017, up 29% quarter-over-quarter.
- 23 funds opened new Syneron Medical Ltd positions in Q1 2017 and 11 closed out, a net change of +12 holders.
- The largest Syneron Medical Ltd buyer in Q1 2017 was Discovery Group I, an estimated $11.8M added.
- The largest Syneron Medical Ltd seller in Q1 2017 was Senvest Management, an estimated $15.2M sold.
Based on aggregated 13F filings for Q1 2017.